Access cutting-edge central centrifugal cicatricial alopecia (ccca) treatment through this phase 2 clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Baltimore location
Preparing your pre-screening questions…
Access central centrifugal cicatricial alopecia (ccca) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related central centrifugal cicatricial alopecia (ccca) treatment provided free
Check if you qualify for this central centrifugal cicatricial alopecia (ccca) clinical trial in Baltimore, MD
No-Cost Study Care
Local to Baltimore
Convenient for MD residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this pilot clinical trial is to learn if tirzepatide can treat active central centrifugal cicatricial alopecia (CCCA), a type of permanent scarring hair loss, in adults. The main questions it aims to answer are: * Does tirzepatide improve the symptoms and signs of active CCCA? * Does tirzepatide change the activity of genes in the scalp, especially genes related to scarring? * Does tirzepatide promote hair regrowth? Participants will: * Inject tirzepatide once a week for 12 months. * Visit the clinic for scalp examinations, photographs, and other health assessments. * Have scalp biopsies at the beginning of the study and after 6 months of treatment. * Have blood tests and other safety monitoring during the study. There is no separate comparison group. Researchers will compare each participant's results during treatment with the participant's results at the beginning of the study.
Sponsor: Johns Hopkins University
Yes, this clinical trial (NCT07734870) has an active research site in Baltimore, MD that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for central centrifugal cicatricial alopecia (ccca) treatment options in Baltimore, MD, this clinical trial (NCT07734870) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced central centrifugal cicatricial alopecia (ccca) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all central centrifugal cicatricial alopecia (ccca) clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Baltimore — not just this study.
Browse Pulmonary Embolism Trials in Baltimore →